Supplements: Ashwagandha and Testosterone
Wankhede et al. (2015, PMID 26609282): 57 trained men, KSM-66 300mg twice daily for 8 weeks, showed +15.4% serum testosterone vs +2.6% placebo. Subjects were recreational trainees, not elite athletes, with no screening for baseline stress levels.
| Measure | Value | Unit | Notes |
|---|---|---|---|
| Evidence Tier | 2 | tier | Moderate — consistent in stressed populations; effect likely smaller in optimized athletes |
| Testosterone Increase (Wankhede 2015) | +15.4 | % vs +2.6% placebo | KSM-66 300mg twice daily × 8 weeks in 57 recreational male trainees |
| Testosterone Increase (Lopresti 2019) | +14.7 | % | KSM-66 240mg/day × 16 weeks in stressed men; cortisol also fell significantly |
| Effective KSM-66 Dose | 300–600 | mg/day | Chandrasekhar 2012: 300mg vs 600mg showed similar cortisol reduction — dose ceiling effect |
| Cortisol Reduction | 27.9 | % (Chandrasekhar 2012) | 300mg KSM-66 twice daily; reduced serum cortisol by 27.9% vs placebo |
| Study Population | stressed, sub-optimally sleeping | — | Critical confound: most studies enroll men with elevated baseline stress — not optimized athletes |
Ashwagandha’s testosterone data is more credible than most supplements in the hormonal support category — but the context matters as much as the numbers.
The Core Mechanism
Ashwagandha does not directly stimulate testosterone synthesis. It downregulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol secretion. The testosterone connection is indirect: cortisol and testosterone share upstream steroid precursors (particularly pregnenolone). When cortisol is chronically elevated — as in chronic psychological stress, poor sleep, or overtraining — those precursors are shunted toward cortisol production, suppressing testosterone synthesis.
Reducing cortisol by 27.9% (Chandrasekhar 2012) frees up precursor availability, allowing testosterone to rise toward its natural ceiling. This is not a testosterone booster; it is a cortisol reducer that secondarily normalizes testosterone.
Study-by-Study Breakdown
| Study | Population | Extract | Dose | Testosterone Change | Cortisol Change | Confounds | Quality |
|---|---|---|---|---|---|---|---|
| Wankhede 2015 (PMID 26609282) | 57 recreational trained men | KSM-66 | 300mg 2×/day × 8 wk | +15.4% vs +2.6% placebo | Not measured | No baseline stress screening | Moderate |
| Lopresti 2019 (PMID 30854916) | Stressed adults (elevated PSS) | KSM-66 | 240mg/day × 16 wk | +14.7% | Significant reduction | Enrolled for elevated stress — population effect unclear | Moderate |
| Chandrasekhar 2012 (PMID 23439798) | Adults with chronic stress | KSM-66 | 300mg 2×/day × 60 days | Not primary outcome | -27.9% | Focuses on stress/anxiety; T increase inferred from mechanism | Moderate |
| Langade 2019 | Stressed adults | KSM-66 | 300mg 2×/day × 10 wk | Not measured | Improved sleep quality | Sleep as primary outcome; T not assessed | Moderate |
Who Responds: The Stress-Cortisol Prerequisite
The pattern across studies is consistent: the men who show testosterone increases have either documented high stress, suboptimal sleep, or are recreational (not elite) trainees. When cortisol is already low — in well-rested, low-stress individuals — there is no suppressive mechanism for ashwagandha to remove.
This has practical implications: an elite athlete with optimized sleep, managed stress, and regular recovery protocols should not expect +15% testosterone from KSM-66. An office worker with poor sleep, chronic workplace stress, and a new training program might.
The DHEA-S Pathway
Some studies show modest DHEA-S increases alongside testosterone. DHEA-S is produced by the adrenal cortex and is an upstream precursor to both androgens and glucocorticoids. By modulating the adrenal stress response, ashwagandha may shift precursor utilization away from cortisol production toward DHEA-S and downstream androgens. This remains a plausible secondary mechanism rather than a confirmed primary effect.
Dose and Formulation
Both major testosterone RCTs used KSM-66 at 300mg twice daily. Chandrasekhar’s work showed similar cortisol reduction at 300mg versus 600mg daily, suggesting a ceiling effect. For testosterone-specific goals, use 300mg KSM-66 twice daily with food. Generic ashwagandha root powder at unspecified withanolide content cannot be assumed equivalent to KSM-66.
Related Pages
Sources
- Wankhede S, et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015;12:43. PMID 26609282
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PMID 30854916
- Chandrasekhar K, et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. PMID 23439798
Frequently Asked Questions
Does ashwagandha directly increase testosterone production?
No. The mechanism is indirect via HPA axis downregulation. Chronically elevated cortisol competes with testosterone for shared precursors in the steroidogenesis pathway — particularly pregnenolone. By reducing cortisol (demonstrated at 27.9% reduction in Chandrasekhar 2012), ashwagandha removes a suppressive signal, allowing testosterone production to approach its genetically determined ceiling. This is restoration, not enhancement beyond normal.
Will ashwagandha raise my testosterone if I already sleep well and have low stress?
Probably not significantly. The two main testosterone RCTs enrolled men with elevated stress scores or suboptimal sleep. If your cortisol is not chronically elevated — meaning you sleep 7–9 hours, manage psychological stress, and do not have overtraining syndrome — the primary mechanism through which ashwagandha raises testosterone has no substrate to act on. Effect size in truly optimized athletes is likely near zero.
What is KSM-66 and why does it matter?
KSM-66 is a patented, standardized Withania somnifera root extract containing at least 5% withanolides. Both Wankhede (2015) and Lopresti (2019) used KSM-66 specifically. Generic ashwagandha powder with unlisted withanolide content has not been validated in RCTs. When choosing an ashwagandha supplement for any documented purpose, use a product standardized to a KSM-66 or Sensoril equivalent — not generic root powder.
Is 300mg or 600mg KSM-66 better?
Chandrasekhar et al. (2012, PMID 23439798) compared 300mg twice daily (600mg/day total) against a single 300mg dose. Both produced significant cortisol reduction, with the higher dose showing marginally greater effect that did not reach statistical significance. Given the dose-ceiling pattern, 300mg twice daily is the evidence-based standard dose. There is no evidence supporting doses above 600mg/day.
Does ashwagandha affect DHEA-S levels?
Some studies show modest increases in DHEA-S alongside testosterone increases. DHEA-S is an upstream precursor in the steroidogenesis pathway, and HPA axis modulation may shift precursor utilization toward androgens rather than glucocorticoids. The DHEA-S data is secondary in most studies and not as robust as the cortisol and testosterone findings. Treat it as a plausible mechanism rather than a confirmed independent effect.